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An exploration of the prognostic utility of shortened
dynamic imaging protocols for PET-FDG scans
Qi Wu, Finbarr O’Sullivan, Mark Muzi and David A. Mankoff
Abstract—Standard whole-body clinical fluoro-deoxyglucose
(FDG)-PET scans typically involve imaging for around 15 minutes
about 60 minutes after tracer injection. The scan duration is
often the critical constraint limiting patient through-put. Scans
taken long after tracer injection restrict the ability to assess
vascular and perfusion information that might be revealed by
the early pattern of tracer uptake. On the other hand, early
scanning may compromise the recovery of the late time uptake
(SUV) which in many contexts has well established prognostic
value. In this study, we explore the potential for short-duration
dynamic scans, acquired immediately after tracer injection, to
recover information that can predict late-stage uptake of FDG.
The work involves re-analysis of existing series of dynamic
brain and breast tumour imaging data to simulate the type
of information that would arise from early and late scanning.
Using a collection of machine learning techniques (including
random forests, neural networks, gradient boosting), we find that
short-duration clinical protocols, soon after the tracer injection,
show significant potential to recover the late stage FDG flux
information.
I. INTRODUCTION
POSITRON emission tomography scanning is an importanttool for cancer diagnosis and treatment planning. As the
next generation of PET total-body scanners[1] will have full
coverage of a subject’s blood pools, they may offer potential to
refine the acquisition of clinical scan data in order to extract
more detailed kinetic information. Hence it is of interest to
examine if earlier scanning would allow recovery of more
detailed kinetic parameters and provide enhanced prognostic
benefits relative to the late scan SUVs. In order to examine
this, we undertook a study to evaluate the value of the kinetic
information that might be recovered from short dynamic scans,
acquired immediately after the FDG tracer injection.
II. MATERIALS AND METHODS
We consider data from a brain tumor study reported by
Spence et al.[8] and a locally advanced breast cancer (LABC)
study reported by Mankoff et al.[3]. The brain set consisted
of 14 patients (6 Male, 8 Female) aged between 30 to 65
with malignant Glioma had dynamic PET-FDG scans 2 weeks
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prior to standard radiation treatment. The scan duration was
typically 90 minutes with a few patients images for 70 minutes
or less. All brain studies had frequent arterial sampling. In the
Mankoff et al. study, 53 female LABC patients aged between
32 to 76 underwent 15O-water and 18F-FDG PET imaging
before neo-adjuvant chemotherapy and surgery. Image-based
AIF recovered from a region of interest of left ventricle[7].
Full image data were resampled to simulate the series that
might result from shorter duration imaging sessions. Series
corresponding to the first 15 minutes only and 0-30 minutes
for both brain and breast data.
Fig. 1: Resampled PET-FDG scan data in the brain tumour series: first 15
minutes(green), 0-30 minutes(navy) and clinical setting 60-75 minutes(purple).
A similar resampling approach was used for the breast series.
A. Mixture Analysis and Residue Mapping
Raw dynamic scan data were processed, using a mixture
analysis[5, 6], to recover voxel-level metabolic variables - see
Figure 2. The basis of this is as follows: The total tissue
concentration, CT (t) is expressed as a convolution between
the tissue response( Residue ) and the arterial input function,
c.f. Meier and Zierler[4].
CT (t) = K
∫ t
0
R(t− s)CP (s)ds = R⊗ CP (t) (1)
where CT (t) is the concentration of radio-labeled tracer in a
tissue region, measured as activity per unit volume (KBq/cm3).
CP (t) is the time-course of the tracer the arterial blood as
activity per millilitre(ml) of blood; R is the tissue residue
function - this can be regarded as a life-table for tracer atoms in
a tissue region. Using mixture model[5] and a non-parametric
approach to residue analysis[6] we can map the residue for
each voxel. From the residue we evaluate Vascular flow and
volume (KB ,VB), distribution flow and volume (KD,VD), flux
(Ki), overall flow (K1) and extraction (Ext=Ki/K1). Each
metabolic variable represents a metabolic feature extracted
from the Residue. So we converted the dynamic image data
to a set of 3-D metabolic images on the voxel bases. The
metabolic mapping process is applied to the full dynamic scan
and also to the shorter 0-15 minute and 0-30 minute scans. Our
further analysis are based on these datasets - metabolic feature
variables.
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Fig. 2: Concepts of converting dynamic image data to a set of 3-D metabolic images
B. Machine Learning Methods Applied to Voxel-Level Data in
the Metabolic Parameter Domain
A range of machine learning (ML) techniques[2] [multiple
linear regression, Generalized additive models(GAM), random
forests, Neural networks(NN) and Gradient Boosting Ma-
chines(GBM)] were used to construct Voxel-level predictions
of flux derived from the full dynamic data using the metabolic
variables recovered from analysis of shorter duration scans.
We selected a sample of patients as a training set and separate
patient for testing. Within training sets, random samples of
voxels were used, this was to reduce impact of spatial autocor-
relation within images. Model selection used standard training
and test-set schemes for tuning.
Fig. 3: Sample voxel-level mapping of the FDG flux (acquired from the full
dynamic data) using on shorter scan metabolic information and a range of ML
techniques results in breast tumor study
Fig. 4: Sample voxel-level mapping of the FDG flux (acquired from the full
dynamic data) using on shorter scan metabolic information and a range of ML
techniques results in brain tumor study
III. RESULTS
Figure 3 shows the result of the analysis of data from
breast cancer subject. We used Neural network and Generalized
additive model to train the model with flux required from
Fig. 5: Sample voxel-level comparisons between true and predicted flux based
on generalized additive models and random forests.
full dynamic scan as response variable and several kinetic pa-
rameters recovered from shorter duration scans, corresponding
to first 15 minutes and first 30 minutes. And use separate
patient’s dynamic PET data for validation. Lower four images
give the estimated flux image. The tumor region can be easily
identified on these images and 30 minutes early scan can also
shows the tumor characteristics which could has prognostic
value in treatment planning. Similar result for brain tumor
datasets shows in Figure 4. Results for the brain tumor data are
less good but a more refined implementation that incorporates
information about the specific range of tissues involved and
different types of tumor may enhance performance.
IV. CONCLUSION
Voxel level results are mixed with much better performance
in the breast cancer setting. Overall results from this series are
promising and merit more detailed evaluation. This work is
underway.
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